Sartorius (OTCMKTS:SARTF) Upgraded to “Buy” at Zacks Investment Research

Share on StockTwits

Zacks Investment Research upgraded shares of Sartorius (OTCMKTS:SARTF) from a hold rating to a buy rating in a research report sent to investors on Wednesday, Zacks.com reports. Zacks Investment Research currently has $192.00 price objective on the stock.

According to Zacks, “Sartorius AG is a pharmaceutical and laboratory equipment supplier. The company manufactures equipment for biomolecular and microbial separations, cell culture, concentration, fermentation and purification. Sartorius AG is headquartered in Goettingen, Germany. “

SARTF has been the subject of several other research reports. DZ Bank reissued a sell rating on shares of Sartorius in a research report on Tuesday, April 2nd. ValuEngine raised shares of Sartorius from a hold rating to a buy rating in a research report on Friday, March 15th.

OTCMKTS SARTF opened at $171.00 on Wednesday. The company has a debt-to-equity ratio of 0.93, a current ratio of 1.37 and a quick ratio of 0.77. Sartorius has a twelve month low of $109.50 and a twelve month high of $175.25. The stock has a market capitalization of $5.85 billion, a P/E ratio of 56.62 and a beta of -0.05.

Sartorius (OTCMKTS:SARTF) last released its earnings results on Thursday, April 18th. The company reported $0.81 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.65 by $0.16. Sartorius had a net margin of 10.28% and a return on equity of 18.90%. The business had revenue of $494.79 million during the quarter, compared to analysts’ expectations of $439.53 million. As a group, sell-side analysts anticipate that Sartorius will post 3.45 earnings per share for the current year.

About Sartorius

There is no company description available for Sartorius AG.

Read More: Commodities

Get a free copy of the Zacks research report on Sartorius (SARTF)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Sartorius Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sartorius and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Transcontinental Expected to Post Q3 2019 Earnings of $0.53 Per Share
Transcontinental Expected to Post Q3 2019 Earnings of $0.53 Per Share
Q3 2019 EPS Estimates for Franco Nevada Corp Raised by Raymond James
Q3 2019 EPS Estimates for Franco Nevada Corp Raised by Raymond James
Q3 2019 EPS Estimates for Continental Resources, Inc. Decreased by Jefferies Financial Group
Q3 2019 EPS Estimates for Continental Resources, Inc. Decreased by Jefferies Financial Group
Equities Analysts Set Expectations for Eni SpA’s Q3 2019 Earnings
Equities Analysts Set Expectations for Eni SpA’s Q3 2019 Earnings
Jefferies Financial Group Weighs in on Taubman Centers, Inc.’s Q3 2019 Earnings
Jefferies Financial Group Weighs in on Taubman Centers, Inc.’s Q3 2019 Earnings
William Blair Analysts Increase Earnings Estimates for BioDelivery Sciences International, Inc.
William Blair Analysts Increase Earnings Estimates for BioDelivery Sciences International, Inc.


© 2006-2019 Ticker Report